Astute Analytica has released a comprehensive report titled North America & Europe Nalmefene Hydrochloride Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.

Each single-dose Zurnai autoinjector delivers a dose of 1.5mg nalmefene (base) in 0.5mL. The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for ...

is the first nalmefene hydrochloride auto-injector for known or suspected opioid overdose in people aged 12 years and older. Medscape Medical News, August 08, 2024 Alert EMA Says Don't Mix Mysimba ...

Naloxone and nalmefene are non-selective tertiary opioid antagonists that are currently available. Neither drug is selective for µ-opioid receptors in the GI tract (both drugs cross the blood ...

CMS has also finalized payments for new opioid agonist and antagonist medications approved by the FDA, including nalmefene hydrochloride nasal spray and a new injectable buprenorphine product.

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

Naltrexone oral tablet is a generic prescription drug used to treat certain substance use disorders. This drug can interact with other medications. For example, naltrexone can interact with ...